Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Advanced Malignancy: A Phase Ib Trial
Authors: R. G. Steis, L. A. VanderMolen, D. L. Longo, J. W. Clark, J. W. Smith, W. C. Kopp, F. W. Ruscetti, S. P. Creekmore, L. J. Elwood, J. Hursey, W. J. Urba
Journal: JNCI Journal of the National Cancer Institute (1990)

Journal Article Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Advanced Malignancy: A Phase Ib Trial Get access Ronald G. Steis, Ronald G. Steis * Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute-Frederick Cancer Research FacilityFrederick, MD. * Correspondence to: Ronald G. Steis, M.D., National Cancer Institute-Frederick Cancer Research Facility, 501 W. Seventh St., Frederick, MD 21701. Search for other works by this author on: Oxford Academic PubMed Google Scholar Louis A. VanderMolen, Louis A. VanderMolen Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute-Frederick Cancer Research FacilityFrederick, MD. Search for other works by this author on: Oxford Academic PubMed Google Scholar Dan L. Longo, Dan L. Longo Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute-Frederick Cancer Research FacilityFrederick, MD. Search for other works by this author on: Oxford Academic PubMed Google Scholar Jeffrey W. Clark, Jeffrey W. Clark Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute-Frederick Cancer Research FacilityFrederick, MD. Search for other works by this author on: Oxford Academic PubMed Google Scholar John W. Smith, II, John W. Smith, II Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute-Frederick Cancer Research FacilityFrederick, MD. Search for other works by this author on: Oxford Academic PubMed Google Scholar William C. Kopp, William C. Kopp Clinical Immunology Services Program Resources, Inc., National Cancer Institute-Frederick Cancer Research FacilityFrederick MD. Search for other works by this author on: Oxford Academic PubMed Google Scholar Francis W. Ruscetti, Francis W. Ruscetti Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute-Frederick Cancer Research FacilityFrederick, MD. Search for other works by this author on: Oxford Academic PubMed Google Scholar Stephen P. Creekmore, Stephen P. Creekmore Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute-Frederick Cancer Research FacilityFrederick, MD. Search for other works by this author on: Oxford Academic PubMed Google Scholar Lori J. Elwood, Lori J. Elwood Laboratory of Pathology, National Cancer InstituteBethesda, MD. Search for other works by this author on: Oxford Academic PubMed Google Scholar Jean Hursey, Jean Hursey Frederick Memorial HospitalFrederick, MD. Search for other works by this author on: Oxford Academic PubMed Google Scholar ... Show more Walter J. Urba Walter J. Urba Clinical Immunology Services Program Resources, Inc., National Cancer Institute-Frederick Cancer Research FacilityFrederick MD. Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 82, Issue 8, 18 April 1990, Pages 697–703, https://doi.org/10.1093/jnci/82.8.697 Published: 18 April 1990 Article history Received: 06 October 1989 Revision received: 29 December 1989 Accepted: 08 January 1990 Published: 18 April 1990